ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Wednesday reported a loss of $66.7 million in its first quarter.
The Rockville, Maryland-based company said it had a loss of $1.53 per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.52 per share.
The biotechnology company posted revenue of $19.1 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $30.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a RGNX">Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX